Back to search

Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)

NCT00203580

PHASE4INTERVENTIONAL
University of Calgary
910 participants
Started 1994-12 · Completed 2002-03
Status: Completed (as of 12-23-2025)

Conditions

ThrombosisThromboembolismVenous Thrombosis

Interventions

DRUG: Tinzaparin sodium

Linked Papers (from SciSciNet-V2)

Total Papers4
Background
0
Result
0
Derived
0
Unknown
4
View on ClinicalTrials.gov

Total Citations Per Year

Brief Summary

The purpose of this study is to assess the long-term treatment of patients with proximal venous thrombosis through the administration of subcutaneous low-molecular-weight heparin (tinzaparin sodium) versus the standard care use of intravenous heparin followed by oral warfarin sodium.

Sort by:

Background Papers0

No background papers linked

Result Papers0

No result papers linked

Derived Papers0

No derived papers linked

Unknown Papers4

Random-Effects Models for Longitudinal Data
1982
8,551 citations
A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis
1996
1,206 citations
Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at Home
1996
1,132 citations
The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators.
1991
155 citations